Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

California ephedrine

This article was originally published in The Tan Sheet

Executive Summary

Bill introduced by Assemblywoman Susan Davis (D) is now on state Senate calendar, scheduled for a June 26 hearing. HR 2294 would prohibit sale of supplements containing ephedrine unless labeling refers to potential adverse reactions and contraindications and provides warnings to those under 18 years of age (1"The Tan Sheet" March 6, In Brief). The bill was assigned to the Committee on Business & Profession June 8. California legislation passed earlier this year limits the amount of pseudoephedrine-containing OTCs that can be purchased at one time to curb illegal methamphetamine production. On Capitol Hill, S 486, which includes similar provisions, remains before the House Commerce/Health & Environment subcommittee (2"The Tan Sheet" June 5, p. 6)

You may also be interested in...



California Ephedrine Bill Slated For Senate Consideration Aug. 28

California legislation requiring warning labels on ephedra-containing dietary supplements passed out of the Senate Appropriations Committee Aug. 24 and is expected to go to the state Senate floor the week of Aug. 28. Assembly Bill 2294 was introduced by Assemblywoman Susan Davis (D) Feb. 24.

California Ephedrine Bill Slated For Senate Consideration Aug. 28

California legislation requiring warning labels on ephedra-containing dietary supplements passed out of the Senate Appropriations Committee Aug. 24 and is expected to go to the state Senate floor the week of Aug. 28. Assembly Bill 2294 was introduced by Assemblywoman Susan Davis (D) Feb. 24.

California Ephedrine Bill Slated For Senate Consideration Aug. 28

California legislation requiring warning labels on ephedra-containing dietary supplements passed out of the Senate Appropriations Committee Aug. 24 and is expected to go to the state Senate floor the week of Aug. 28. Assembly Bill 2294 was introduced by Assemblywoman Susan Davis (D) Feb. 24.

Related Content

Topics

UsernamePublicRestriction

Register

PS091322

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel